PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics (NASDAQ: PTCT) has announced the approval of inducement grants for eight new employees on December 13, 2024. The grants include non-statutory stock options to purchase 1,725 shares of common stock and 5,060 restricted stock units (RSUs). The stock options were priced at $46.37 per share, matching the closing price on the grant date, and have a 10-year term. Both options and RSUs vest over four years, with options vesting 25% after one year and 6.25% quarterly thereafter, while RSUs vest 25% annually. These awards were approved by PTC's Compensation Committee as part of new hire compensation packages under Nasdaq Listing Rule 5635(c)(4).
PTC Therapeutics (NASDAQ: PTCT) ha annunciato l'approvazione di indennità per otto nuovi dipendenti il 13 dicembre 2024. Le indennità includono opzioni su azioni non statutarie per l'acquisto di 1.725 azioni ordinarie e 5.060 unità di azioni vincolate (RSU). Le opzioni su azioni sono state valutate a $46,37 per azione, corrispondendo al prezzo di chiusura alla data della concessione, e hanno una durata di 10 anni. Sia le opzioni che le RSU si maturano nel corso di quattro anni, con il 25% delle opzioni che matura dopo un anno e il 6,25% trimestralmente successivamente, mentre le RSU maturano il 25% annualmente. Questi riconoscimenti sono stati approvati dal Comitato per la Compensazione di PTC come parte dei pacchetti di compensazione per i nuovi assunti ai sensi della Regola di Quotazione Nasdaq 5635(c)(4).
PTC Therapeutics (NASDAQ: PTCT) ha anunciado la aprobación de subvenciones de incentivos para ocho nuevos empleados el 13 de diciembre de 2024. Las subvenciones incluyen opciones sobre acciones no estatutarias para comprar 1.725 acciones ordinarias y 5.060 unidades de acciones restringidas (RSUs). Las opciones sobre acciones se fijaron en $46.37 por acción, coincidiendo con el precio de cierre en la fecha de la concesión, y tienen un plazo de 10 años. Tanto las opciones como las RSUs maduran durante cuatro años, con opciones que maduran un 25% después de un año y un 6,25% trimestralmente a partir de ahí, mientras que las RSUs maduran un 25% anualmente. Estas concesiones fueron aprobadas por el Comité de Compensación de PTC como parte de los paquetes de compensación para nuevos empleados bajo la Regla de Cotización Nasdaq 5635(c)(4).
PTC Therapeutics (NASDAQ: PTCT)는 2024년 12월 13일에 8명의 새로운 직원에 대한 유인 보상 승인 소식을 전했습니다. 보상에는 1,725주의 보통주를 구매할 수 있는 비법정 주식 옵션과 5,060개의 제한 주식 단위(RSU)가 포함됩니다. 주식 옵션의 가격은 $46.37로 책정되었으며, 이는 보상 날짜의 종가와 일치하고, 10년의 기간을 가집니다. 옵션과 RSU 모두 4년에 걸쳐 분할 지급되며, 옵션은 1년 후 25%가 지급되고 이후 매 분기 6.25%씩 지급되며, RSU는 매년 25%가 지급됩니다. 이러한 보상은 Nasdaq 상장 규칙 5635(c)(4)에 따라 새 직원 보상 패키지의 일환으로 PTC의 보상 위원회에 의해 승인되었습니다.
PTC Therapeutics (NASDAQ: PTCT) a annoncé l'approbation de subventions d'incitation pour huit nouveaux employés le 13 décembre 2024. Les subventions comprennent des options d'achat d'actions non statutaires pour l'acquisition de 1.725 actions ordinaires et de 5.060 unités d'actions restreintes (RSU). Les options d'achat d'actions ont été fixées à $46,37 par action, correspondant au prix de clôture à la date d'attribution, et ont une durée de 10 ans. Les options et les RSU acquièrent leurs droits sur une durée de quatre ans, avec 25 % des options acquises après un an et 6,25 % tous les trimestres par la suite, tandis que les RSU s'acquièrent à raison de 25 % par an. Ces récompenses ont été approuvées par le comité de rémunération de PTC dans le cadre des packages de rémunération pour les nouveaux employés conformément à la règle de cotation Nasdaq 5635(c)(4).
PTC Therapeutics (NASDAQ: PTCT) hat am 13. Dezember 2024 die Genehmigung von Anreizgewährungen für acht neue Mitarbeiter bekannt gegeben. Die Gewährungen beinhalten nicht statutäre Aktienoptionen zum Kauf von 1.725 Stammaktien und 5.060 Restricted Stock Units (RSUs). Die Aktienoptionen wurden zu einem Preis von 46,37 $ pro Aktie festgelegt, was dem Schlusskurs am Gewährungstag entspricht, und haben eine Laufzeit von 10 Jahren. Sowohl Optionen als auch RSUs werden über vier Jahre erworben, wobei die Optionen nach einem Jahr um 25 % und anschließend vierteljährlich um 6,25 % reifen, während die RSUs jährlich um 25 % reifen. Diese Auszeichnungen wurden vom Vergütungsausschuss von PTC als Teil der Vergütungspakete für neue Mitarbeiter gemäß der Nasdaq-Listungsregel 5635(c)(4) genehmigt.
- None.
- None.
The inducement grants were approved by PTC's Compensation Committee on Dec. 13, 2024, and are being made as an inducement material to each employee's acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
All stock option awards have an exercise price of
ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. PTC's mission is to provide access to best-in-class treatments for patients who have little to no treatment options. PTC's strategy is to leverage its strong scientific and clinical expertise and global commercial infrastructure to bring therapies to patients. PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn and X.
For more information please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302334077.html
SOURCE PTC Therapeutics, Inc.
FAQ
What are the terms of PTC Therapeutics' December 2024 inducement grants?
How many new employees received PTCT inducement grants in December 2024?
What is the exercise price for PTCT's December 2024 stock option grants?
What is the vesting schedule for PTCT's December 2024 RSU grants?
